Lauren Belive of Lyft on Transportation for Patients with Cancer
Lauren Belive of Lyft spoke at the Cancer Support Community's "Cancer Moonshot: One Year Later" about the work Lyft is doing to help patients with cancer make it to their appointments.
Durvalumab Garners Similar OS, Albeit Varied PFS, Outcomes in EGFR+ and EGFR-Wildtype NSCLC Subgroups
Quizartinib Extends Overall Survival Across Multiple Subgroups in FLT3-ITD+ AML
Repotrectinib Showcases Early Intracranial Responses in Select ROS1+ NSCLC
Osimertinib May Be More Effective in Frontline EGFR+ NSCLC When Combined With Chemo
